Anti-AIDS drug price-cut announced

AFRICA: Anti-AIDS drug price-cut announced

JOHANNESBURG, 2 Sep 2005 (PLUSNEWS) - Developing countries will be paying less for two anti-AIDS drugs produced by multinational pharmaceutical company, Gilead Sciences.
In a statement Gilead said it had dropped the cost of Viread by 31 percent and that of Truvada by 12 percent. Both medications are already sold at no-profit prices in 97 developing countries around the world.

According to the company, the no-profit price of a 30-day supply of Viread was now US $17, while a one-month supply of Truvada cost $26.25.

However, Gilead stressed that only countries enrolled in the company's antiretroviral access programme would benefit from the price-cut.

[ENDS]

[Back] [Home Page]

Click here to send any feedback, comments or questions you have about PlusNews Website or if you prefer you can send an Email to Webmaster

Copyright © IRIN 2005
The material contained on www.PlusNews.org comes to you via IRIN, a UN humanitarian news and information service, but may not necessarily reflect the views of the United Nations or its agencies.
All PlusNews material may be reposted or reprinted free-of-charge; refer to the IRIN copyright page for conditions of use. IRIN is a project of the UN Office for the Coordination of Humanitarian Affairs.